80073101 - Frontiers in Clinical Infectious Diseases

Wednesday, May 12, 2027, 8:00 AM - Friday, May 14, 2027, 5:00 PM, The Johns Hopkins Bloomberg Center located at 555 Pennsylvania NW, Washington, DC 20001, Washington, DC


Infectious diseases remain a dynamic and fascinating field replete with new challenges facing outpatient primary care providers, hospital medicine practitioners, and ID specialists alike. This activity is designed to explore major infectious disease topics of particular relevance to our target audience, including infectious disease specialists, hospitalists, primary care physicians, and midlevel providers.

1. Recognize and manage Candida auris and other fungal pathogens in varied care settings.
2. Implement updated HIV care practices, improve retention, viral suppression, and offer PrEP and doxyPEP where indicated.
3. Select empiric and directed regimens for priority AMR pathogens consistent with 2026 IDSA guidance, including appropriate oral step down and avoidance of suboptimal agents.
4. Apply the 2026 NTCA community RIR guideline to start, continue, and discontinue TB isolation restrictions safely and efficiently.

Mitigation of Relevant Financial Relationships

Johns Hopkins University adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

No faculty are available for this activity at this time.